Familial AD (FAD) mutations in APP or presenilins are known to have significant effects on the production of Aβ42 and Aβ40 peptides and the Aβ42:Aβ40 ratio [22,23,24,25]. The gene discussed is APP; the disease is Alzheimer disease.